Replies to post #42754 on Relief Therapeutics Holding AG (RLFTF)

[changes_iv]

CDC and its partners are actively monitoring reports of myocarditis and pericarditis after COVID-19 vaccination. Active monitoring includes reviewing data and medical records and evaluating the relationship to COVID-19 vaccination.

Myocarditis is inflammation of the heart muscle, and pericarditis is inflammation of the outer lining of the heart. In both cases, the body’s immune system causes inflammation in response to an infection or some other trigger. Learn more about myocarditis and pericarditis.external icon Seek medical care if you or your child have symptoms of these conditions within a week after COVID-19 vaccination.

https://www.cdc.gov/coronavirus/2019-ncov/vaccines/safety/myocarditis.html

[changes_iv]

ARE RELIEF’S AVIPTADIL BENEFITS MULTI DIMENSIONAL??? SHOULD WE DEFEND AVIPTADIL ANTI-INFLAMMATORY APPLICATION???

Try to Attack Your Own Patent

This tip is less intuitive than some of the others, but possibly your best bet at creating a valuable patent. You want to be prepared for questions by the USPTO when you submit your application. The better prepared you are to defend your design, including its novelty, utility, and non-obviousness, the more likely you are to receive a patent.

Likewise, you should assume that competitors will want to find ways to profit from a similar design. Think like a competitor and try to find ways they might circumvent your patent – with as many variations as possible.

https://michelsonip.com/how-to-strengthen-your-patent/